# Haupt Pharma Amareg GmbH – FDA Inspection, Jul 26, 2024

Source: https://www.keypedia.com/records/fda_inspections/haupt-pharma-amareg-gmbh/c2c3b316-3961-4c7b-9293-5fcc6a5dc890
Source feed: FDA_Inspections

> FDA inspection 1274881 of Haupt Pharma Amareg GmbH, July 26, 2024. Classification: Voluntary Action Indicated (VAI). 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1274881
- Company Name: Haupt Pharma Amareg GmbH
- Inspection Date: 2024-07-26
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1134674 - 2019-06-07
- [FDA Inspection 1038904 - 2017-11-10](https://www.keypedia.com/records/fda_inspections/haupt-pharma-amareg-gmbh/ff1d6434-13f7-4c0d-9c4d-3797bdc4ffbc)
- FDA Inspection 986248 - 2016-08-26
- FDA Inspection 857318 - 2013-11-22
- FDA Inspection 727709 - 2011-05-18

Company: https://www.keypedia.com/companies/haupt-pharma-amareg-gmbh/6badd9f8-b509-4f18-bbcf-4fcd058ba5b3

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
